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Abstract Mast cells differentiate from circulating pluripo-
tent hematopoietic progenitors. During this differentiation,
the progenitor cells are exposed to changes in oxygen avail-
ability. HIF1A is the major sensor of oxygen concentration
in mammalian cells. We investigated the expression of
HIF1A during the in vitro differentiation of peripheral
blood-derived progenitors into human mast cells. In a series
of experiments, we determined the changes in CD34 expres-
sion, selected mast cell markers, and HIF1A in human mast
cell cultures. While the expression of CD34 dramatically
decreased, the expression of mast cell-specific genes, in-
cluding FCER1A, MS4A2, TPSB2, and CMA1, steadily in-
creased. HIF1A expression similarly increased during mast
cell differentiation, reaching its maximum level at five
weeks of culture. The analysis of the promoter methylation
status showed decreasing levels of methylation at the HIF1A
promoter, increasing levels of methylation at the CD34
promoter, and no significant changes in other genes. In
silico analysis of the promoter regions of these genes re-
vealed large CpG islands in close proximity to the HIF1A
and CD34 transcription initiation sites, but not in other
investigated genes. In conclusion, in vitro mast cell differ-
entiation was associated with decreased CD34 expression
and increased HIF1A expression. These changes were
paralleled with changes in the methylation status of the
respective promoters, suggesting that DNA methylation-
dependent epigenetic regulation mediates the gene expres-
sion changes involved in maintaining the phenotype of
hematopoietic stem cells and mature mast cells. Therefore,
the baseline expression of HIF1A is epigenetically regulated
in a cell type- and differentiation stage-specific fashion.
Keywords Human mast cells . Differentiation . Hif1a .
Cd34 . Epigenetic regulation
Introduction
Mast cells originate from pluripotent hematopoietic cells
that are released from the bone marrow into the circu-
lation and differentiate in the peripheral tissues
(Metcalfe et al. 1997). One of the factors that differen-
tially influences cellular physiology at different sites in
the human body is the partial pressure of oxygen.
Relatively low oxygen concentrations, often referred to
as physiological hypoxia or physioxia, are characteristic
of the bone marrow and the skin (Carreau et al. 2011;
MacDougall and McCabe 1967). While the partial pres-
sure of oxygen in various tissues ranges from 5 to
15 mmHg, the partial pressure of oxygen observed in
blood plasma is significantly higher, reaching 40 mmHg
(Carreau et al. 2011; MacDougall and McCabe 1967).
Thus, during the differentiation of bone marrow pro-
genitors into peripheral mature mast cells, the cells are
exposed to a gradation of oxygen availability. The ma-
jor sensor of oxygen concentration in mammalian cells
is the dimeric transcription factor HIF-1, which consists
of the protein product of HIF1A, known as HIF-1α, and
the protein product of ARNT, known as HIF-1β
(Semenza 2001). The amount of HIF-1α in the cell
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depends on the availability of oxygen, which induces
HIF-1α degradation (Semenza 2001), and cell type-
specific regulation of HIF1A expression at the transcrip-
tional (Gorlach 2009; Lauzier et al. 2007; Walczak-
Drzewiecka et al. 2008), and epigenetic levels
(Koslowski et al. 2010; Walczak-Drzewiecka et al.
2010). The role of HIF-1α-mediated oxygen sensing is
not limited to the physiological response to hypoxic
stress, but is also important for other processes, such
as astrocyte differentiation (Mutoh et al. 2012), and the
maintenance of a quiescent state of bone marrow hema-
topoietic stem cells (Takubo et al. 2010). HIF-1α is also
involved in innate immune responses to bacterial infec-
tion, where it upregulates antibacterial functions of
granulocytes , macrophages , and kera t inocytes
(Peyssonnaux et al. 2008; Peyssonnaux et al. 2005;
Zinkernagel et al. 2007).
We previously reported that CD34+ hematopoietic pro-
genitors isolated from the peripheral blood and the bone
marrow demonstrated significantly lower levels of HIF1A
expression as compared to mature PBMC (Walczak-
Drzewiecka et al. 2010). This, combined with the observa-
tion of epigenetic silencing of HIF1A in the HMC-1 human
mast cell line (Walczak-Drzewiecka et al. 2010), prompted
us to investigate the expression of HIF1A during in vitro




Ficoll-Paque cell separation solution was purchased
from GE Healthcare (Uppsala, Sweden). The AC133
cell isolation kit and LS+ cell separation columns were
purchased from Miltenyi Biotech (Bergisch Gladbach,
Germany). StemSpan culture medium was purchased
from Stem Cell Technologies (Vancouver, Canada).
Fetal calf serum (FCS) was bought from PAA (Pasching,
Austria), and penicillin/streptomycin was acquired from
Invitrogen/Gibco (Carlsbad, California). Human recom-
binant stem cell factor (rhSCF), human rhIL-6 and hu-
man rhIL-3 were purchased from R&D Systems (Abingdon,
UK).
CD133+ cell isolation
The culture of primary human mast cells was initiated
from a population of CD133+ cells that were obtained from
buffy coat preparations as per Holm et al. (2008). Fresh
buffy coats from a total of 35 anonymous blood donors
(Table 1) were obtained from the Regional Center of
Blood Donation and Blood Treatment in Lodz, Poland
according to the center’s legal guidelines. Briefly, the
50 ml buffy coats were diluted in three volumes of PBS,
gently layered on a Ficoll-Paque gradient, and centrifuged at
room temperature for 30 min at 450×g. The interface layer
of mononuclear cells was harvested and washed in PBS.
Table 1 Source of cells employed for analysis of gene expression
Donor no. PBMC CD133+ Week of mast cell culture
1st 2nd 3rd 4th 5th
1 ■ ■ ■ ■ ■ ■
2 ■ ■
3 ■ ■ ■
4 ■ ■ ■ ■ ■
5 ■ ■ ■ ■ ■
6 ■ ■ ■
7 ■ ■ ■ ■ ■ ■
8 ■ ■ ■
9 ■ ■ ■ ■ ■ ■
10 ■ ■ ■
11 ■ ■ ■
12 ■ ■ ■ ■ ■
13 ■ ■ ■ ■
14 ■ ■ ■ ■ ■ ■
15 ■ ■ ■ ■
16 ■ ■ ■ ■
17 ■ ■ ■ ■
18 ■ ■ ■ ■
19 ■ ■ ■
20 ■ ■ ■
21 ■ ■
22 ■ ■ ■
23 ■ ■ ■
24 ■ ■ ■
25 ■ ■ ■
26 ■ ■ ■
27 ■ ■ ■
28 ■ ■ ■
29 ■ ■ ■
30 ■ ■ ■
31 ■ ■ ■ ■
32 ■ ■
33 ■
34 ■ ■ ■
35 ■ ■ ■ ■
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The CD133+ cells were separated from the mononuclear
cells using a magnetic separation column as follows: the
mononuclear cells were resuspended in 300 μl of MACS
buffer and were pre-treated with an FcR blocking reagent at
100 μl/108 cells. The cells were incubated with AC133
MicroBeads for 30 min at 4 °C. After incubation, the cells
were washed with MACS buffer. The pellet was then
resuspended in 500 μl of MACS buffer and passed through
the separation columns. The LS+ column was washed three
times with 3 ml of MACS buffer while in the magnetic field,
and the CD133+ cells were retained in the column, while the
lineage negative cells were eluted. The column was re-
moved from the magnet, and the CD133+ cells were col-
lected and counted in Trypan blue.
Cell culture and differentiation of mast cells
The mast cell cultures were performed as described by Holm
et al. (2008). Briefly, the cells were maintained at a density
of 5×105/ml in StemSpan medium supplemented with
100 ng/ml rhSCF, 50 ng/ml rhIL-6, 1 ng/ml rhIL-3, and
penicillin/streptomycin solution. IL-3 was removed from
the medium after three weeks of culture, and 10 % FCS
was introduced into the culture medium after six weeks. The
medium was renewed once per week. For the gene expres-
sion analysis, 33 mast cell cultures were initiated from
CD133+ cells that were obtained from individual donors.
At the time points indicated in Table 1, aliquots of the cell
suspensions were withdrawn from the culture for analysis.
Seven cultures were continued until the seventh week. For
the DNA methylation analysis, additional 8 cultures were
initiated from CD133+ cells that were obtained from indi-
vidual donors. At 3 and 5 weeks of culture, aliquots of equal
numbers of cells from two of the cultures, or in one case
four, were withdrawn, pooled, and analyzed.
Real-time RT-PCR
RNA was isolated using TRI Reagent® from Molecular
Research Center. Aliquots of 1–5 μg of total RNA were
reverse-transcribed using RevertAid™ H Minus M-MuLV
Reverse Transcriptase (Fermentas, Vilnius, Lithuania) in the
presence of oligo-dT18 primers in a 20 μl RT reaction. The
level of cognate cDNA was measured by real-time
PCR amplification performed on a LightCycler 480
(Roche, Basel, Switzerland) using SYBR Green I master
mix (Roche). The cycling conditions were as follows:
95 °C 10 s, 55 °C 10 s, and 72 °C 20 s. The following
intron spanning primers were used: 5′-GAAAGCGCA
AGTCTTCAAAG-3′ and 5′-TGGGTAGGAGATGGAG
ATGC-3′ for HIF1A, 5′-CATCACAGAAACGACAGT
CAA-3′ and 5′-ACTCCGCACAGCTGGAGG-3′ for
CD34, 5′-TGTGGCAGCTGGACTATGAGTCT-3′ and 5′-
ACTTCTCACGCGGAGCTTTTAT-3′ for FCER1A, 5′-
ACAGGAGCCTTCCAGTGTGCCT-3 ′ and 5 ′-CAG
TGGTGGGGATGAGGCCG-3′ for MS4A2, 5′- GGTT
GAACAAGCAGCGGCCC-3 ′ and 5 ′-TTCCTGGT
GCTCAGGCCCGT-3′ for FCER1G, 5′-GGGGAGGGGA
GAGCCCACTG-3′ and 5′-CTTGACGTCCGGTCCC
ACGC-3′ for TPSAB1, 5′- TCATGCCAGGGCGACTC
CG-3′ and 5′-ACCCAGGTGGACACCCCAGG-3′ for
TPSAB2, and 5′-ACTTCCAACGGTCCCTCAAA-3′ and
5′- CCTCAAGCTTCTGCCATGTG-3′ for CMA1, 5′-ATT
TTCTCTGCGTTCTGCTCCTAC-3′ and 5′-CGCCCA
CGCGGACTATTA fo r KIT, 5 ′ -AGGATGAAA
A A C A A G C A G A C AT C A - 3 ′ a n d 5 ' - C A G A
CTGGATGGCTTGGGATT-3 ′ for CPA3 , 5'-GAAT
GACGCCCTCAATCAAAGT-3 ′ and 5 ′ -TCATC
TTGGGCAGTCACATACA for IL1A, 5′-ACAGATG
AAGTGCTCCTTCCA-3′ and 5′-GTCGGAGATTCGT
AGCTGGAT-3′ for IL1B, 5′-AAGAGACCTTGGCACTG
CTTTC-3′ and 5′-GGAACAGGAATCCTCAGAGTCTCA
for IL5, 5′-TGAGGAGCTGGTCAACATCA-3′ and 5′-
CAGGTTGATGCTCCATACCAT-3′ for IL13, 5′-ATGCCC
GACCTCAACTCCTCCACT-3′ and 5′-GCCACCCAGCT
GCAAGATTTC-3′ for IL16, 5′-GACGCATGCCCTCAATCC-3′
and 5′-TAGAGCGCAATGGTGCAAT-3′ for IL18, 5′-CAAG
GGCTACCATGCCAAC-3′ and 5′-AGGGCCAGGACCTT
GCTG-3′ for TGFB1, 5′-AGGAGGAGGGCAGAATCATCA-3′
and 5′-CTCGATTGGATGGCAGTAGCT-3′ for VEGFA, 5′-
GCAACCAGTTCTCTGCATCA-3′ and 5′-TGGCTGCTCG
TCTCAAAGTA-3′ for CCL3, 5′-ACCACACCCTGCTG
CTTTGC-3′ and 5′-CCGAACCCATTTCTTCTCTGG-3′ for
CCL5, 5′-GGCCAGCCACTACAAGCAGCACT-3′ and 5′-C
AAAGGGGATGACAAGCAGAAAG-3′ for CSF2, 5′-ACT
TTGCAGCCAGGTACGTC-3 ′ and 5 ′ -CTCAAC
CGAGAGATGCGAGC-3′ for TPSG1
HPRT1, HMBS, B2MG, RPL13A, TBP, and ACTB were
chosen as the most reliable reference genes by a selection
procedure that was developed by Vandesompele et al. (2002).
The relative gene expression was calculated using ΔΔCT
method with the geometric mean of selected reference genes.
Genomic DNA isolation and analysis of the in vivo
methylation status of the human HIF1A and CD34 promoters
The genomic DNA from human cells was isolated using
the Genomic DNA Extraction Kit (Panomics, Fremont,
USA). The DNA was then sheared into 500–100 bp
fragments by sonication (6 sets of 10-second pulses on
wet ice) using a VCX130 sonicator (Sonics Inc.,
Newtown, USA). The methylated DNA was isolated
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based on the methylated CpG island recovery assay
(MIRA) (Rauch and P f e i f e r 2005 ) u s i ng a
MethylCollectorTM Ultra Kit (Active Motif, Carlsbad,
USA). The recovered methylated DNA fragments were
purified by phenol/chloroform extraction, followed by
ethanol precipitation, and then analyzed by RT-PCR
with primers specific for the HIF1A promoter (forward:
5′-AGGATCACCCTCTTCGTCG-3′ and reverse: 5′-
GCGGAGAAGAGAAGGAAAGG-3 ′ ; po s i t i on :
−259/−80) and the CD34 promoter (forward: 5′-
ACTCGGTGCGTCTCTCTAGG-3′ and reverse: 5′-
CCGTGAGACTCTGCTCTGC-3′; position: −35/+172).
The relative amount of PCR product was calculated by
transforming the Ct values according to the following
formula: relative amount of PCR product=1,000×(2ΔCt),
where ΔCt=Ctsample−Ctinput.
Bioinformatics
The promoter sequences of all of the analyzed genes were
identified and downloaded from the UCSC genome browser
(Kent et al. 2002). For the analysis of potential methylation
sites in the selected gene promoters, the CpG Island
Searcher was applied (Takai and Jones 2003). The putative
HIF1α binding motifs were identified using MatInspector
Software (Cartharius et al. 2005).
Statistics
The statistical significance of the data was evaluated with
the Student parametric test and the Mann–Whitney and
Kruskal–Wallis nonparametric tests using the SPSS 10 soft-
ware. The statistical analysis of the in vivo methylation data
was performed using a one-way ANOVA followed by the
Dunn’s post hoc test. A p value of 0.05 or lower was
considered statistically significant.
Results
In this study, we employed published experimental pro-
tocols for the culture of human mast cells. To verify the
cell culture protocol, CD133+ cells were purified from
the buffy coat preparations of five independent donors
(>85 % purity), and 1–2×106 cells were cultured for
6 weeks. The cells were then analyzed for the presence
of metachromatically stained granules and for surface
expression of c-Kit and FcεRI. Greater than 92 % of
the cells stained positive for toluidine blue, c-Kit, and
FcεRI (data not shown). Next, the cells were harvested
at the indicated time points and were analyzed by real-
time PCR for the expression of several genes that are
preferentially expressed either in hematopoietic
progenitors or in mature mast cells. As seen in Fig. 1,
CD34 (the marker of hematopoietic progenitors) was
hardly detectable in PBMC but showed a high level of
expression in the purified CD133+ cells 48 h post-
magnetic bead separation. This expression level de-
creased dramatically after the first week of culture and
reached a level comparable to that observed in the
PBMC by the second week of culture. We next ana-
lyzed the expression of a series of genes that are known
to be specifically expressed in mature human mast cells:
FCER1A, which codes for the alpha polypeptide of the
Fc fragment of the high affinity IgE receptor; MS4A2,
which codes for the beta chain of the Fc fragment of
the high affinity IgE receptor; TPSB2, which codes for
the mast cell granule-specific tryptase; and CMA1,
which codes for the mast cell granule-specific chymase,
and KIT which codes for c-Kit receptor. Expression of
KIT has steadily increased from the low level observed
in CD133+ cells (median 0.02) to the significantly
higher expression at the third (median 11.56) and the
fourth (median 19.66) week of culture (data not shown).
As seen in Fig. 2a, the expression of CMA1 in the
PBMC and CD133+ cells was below the level of de-
tection. However, it increased significantly following
two weeks of culture and showed the highest level of
Fig. 1 CD34 expression in differentiating human mast cells. Aliquots
of PBMC obtained from anonymous blood donors were lysed for RNA
isolation (PBMC), and the remaining cells were used for the purifica-
tion of CD133+ cells by magnetic separation. Aliquots of the purified
CD133+ cells were lysed for RNA isolation (CD133+), and the
remaining cells were cultured under mast cell differentiating conditions
for up to five weeks. At the indicated time points, the cells were lysed
for RNA purification. The RNA was used to determine CD34 expres-
sion by real-time RT-PCR. The data obtained from a total of 35 donors
and 33 mast cell cultures, each initiated from a single donor, are
presented as median, lower and upper quartile, and minimum and
maximum for each experimental condition from at least 11 cultures.
* indicates significant differences at p<0.05 as compared to the
CD133+ cells
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expression in the third week of the differentiating cul-
ture. The expression of FCER1A in the PBMC was
above the level of detection, likely due to the presence
of a small fraction of FcεRI positive cells, but was
below the limit of detection in the purified CD133+
cells. FCER1A expression significantly increased within
the first week of the differentiating culture and further
increased, reaching the maximum expression level, in
the fourth week of culture (Fig. 2b). Similar kinetics
were observed for the expression of MS4A2, which was
also undetectable in CD133+ cells: the expression sig-
nificantly increased in the first week of culture and
reached the maximum expression in the third week of
culture (Fig. 2c). The expression of TPSB2 was initially
undetectable in the CD133+ cells. However, it increased
significantly by the second week of culture and steadily
increased until the fifth week, when it reached the
maximum expression level (Fig. 2d) Continuation of
culture until the seventh week previously reported as
optimal time for development mast cell-specific pheno-
type (Holm et al. 2008) did not result in significant
differences in FCER1A and TPSB2 expression as com-
pared to the fifth week (data not shown). Thus, we
observed increased expression of mast cell-specific
genes upon culturing CD133+ cells under mast cell
differentiating conditions. We next investigated the
changes in HIF1A expression during culture. As seen
in Fig. 3, the purified CD133+ cells revealed lower
expression of HIF1A as compared to the PBMC.
During in vitro differentiation, the expression of
HIF1A significantly increased following three weeks of
culture as compared to the CD133+ cells, and remained
Fig. 2 Mast cell-specific gene expression in differentiating human
mast cells. CD133+ cells obtained from PBMC of individual blood
donors by magnetic separation were cultured under mast cell differen-
tiating conditions for up to five weeks. Aliquots of PBMC (PBMC),
purified CD133+ (CD133+), and cell cultured for indicated time were
lysed for RNA purification and the RNAwas used to determine CMA1
(a), FCER1A (b), MS4A2 (c), and TPSB2 (d) expression by real-time
RT-PCR. The data obtained from a total of 35 donors and 33 mast cell
cultures, are presented as median, lower and upper quartile, and min-
imum and maximum for each experimental condition from at least 11
cultures. * indicates significant differences at p<0.05 as compared to
the CD133+ cells
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at this level until the seventh week of culture (data not
shown). Thus, the expression of HIF1A paralleled the
expression of several genetic markers of mast cell dif-
ferentiation. We then analyzed the status of DNA meth-
ylation at the promoters of all the analyzed genes. We
first performed a bioinformatics search for putative CpG
islands in the upstream region of the analyzed genes. As
seen in Table 2, only the upstream regions of CD34 and
HIF1A unambiguously demonstrated the presence of
CpG islands. There were no potential CpG islands
detected in the upstream regions of the TPSB2, CMA1,
MS4A2, and FCER1A genes. We experimentally deter-
mined the level of DNA methylation and found that the
methylation status of the promoter regions of FCER1A,
MS4A2, TPSB2, and CMA1 did not change during the
differentiating culture (data not shown). In contrast, the
methylation of the HIF1A and CD34 promoters changed
during cell differentiation. Upon three weeks of culture
under differentiation conditions, the level of DNA meth-
ylation at the CD34 promoter significantly increased
(Fig. 4a), and the level of DNA methylation at the
HIF1A promoter significantly decreased (Fig. 4b).
Thus, we observed that during mast cell differentiation,
both the expression and the methylation levels of the
CD34 and HIF1A promoter sequences were inversely
related. It has been previously shown that HIF1α is
engaged in the regulation of mast cell cytokine expres-
sion (Sumbayev et al. 2012). To further assess the
potential role of HIF1A in mast cell function, we ana-
lyzed genes of known function that are preferentially
expressed in mast cells (Metcalfe 2008) for potential
HIF-1 binding to hypoxia responsive elements (HRE).
As seen in Table 3, this analysis identified several
cytokine, chemokine and protease genes that are poten-
tially regulated by HIF-1A. We next used the
established human mast cell line LAD-2 to investigate
the effects of hypoxia on the expression of genes that
are potentially regulated by HIF-1α. We observed sig-
nificant increases in the expression of several genes
important for mast cell function, such as: c-Kit, IL-1,
and RANTES (Table 4).
Discussion
We report here that HIF1A expression significantly in-
creased during the differentiation of peripheral blood-
derived CD133+ cells into mast cells. While the level of
HIF1A expression in undifferentiated CD133+ cells was
significantly lower than in the PBMC, the level observed
in mast cells was comparable to the PBMC, which consist
mainly of differentiated hematopoietic cells (Fig. 3). This is
similar to our previously reported observations that CD34+
cells isolated from the bone marrow and the peripheral
Fig. 3 HIF1A and CD34 expression in differentiating human mast
cells. CD133+ cells were obtained from PBMC of individual blood
donors by magnetic separation and were cultured under mast cell
differentiating conditions for up to five weeks. Aliquots of PBMC
(PBMC), purified CD133+ (CD133+), and cell cultured for indicated
time were lysed and the lysates were used for RNA purification. The
RNA obtained from the different cell populations was used to deter-
mine HIF1A expression by real-time RT-PCR. The data obtained from
a total of 35 donors and 33 mast cell cultures, are presented as median,
lower and upper quartile, and minimum and maximum for each exper-
imental condition from at least 11 cultures. * indicates significant
differences at p<0.05 as compared to the CD133+ cells
Table 2 Summary of bioinfor-
matics-based analysis of pro-
moter regions of investigated
genes and experimental analysis
of their methylation status dur-
ing mast cell differentiation
Gene CpG island %GC ObsCpG/ExpCpG Length [bp] Observed change
in methylation upon
differentiation
FCER1A No – – – None
TPSAB1 No – – – None
TPSB2 No – – – None
CMA1 No – – – None
CD34 −197/+200 66.8 0.782 397 Increase
HIF1A −775/+200 68.2 0.809 978 Decrease
MS4A2 No – – – None
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blood revealed lower levels of HIF1A expression than ma-
ture hematopoietic and non-hematopoietic cells (Walczak-
Drzewiecka et al. 2010). Upon culture under differentiating
conditions, the level of HIF1A expression increased in par-
allel to genes encoding characteristic mast cell proteins,
such as the surface receptor for Fc IgE and granule associ-
ated proteases (Fig. 2). This suggested that the observed
changes in HIF1A expression are related to the process of
mast cell differentiation and that increased HIF1A expres-
sion relative to progenitor cells is a marker of mature mast
cells. The level of HIF1A expression in cultures predomi-
nantly containing differentiated mast cells was similar to
that observed in PBMC. This is consistent with the hypoth-
esis that increased HIF1A expression is not necessarily a
phenomenon specific to mast cell differentiation, but might
represent a general phenomenon of the differentiation of
hematopoietic progenitors into mature blood cells.
One possible explanation for the increased baseline
HIF1A expression in resting cells during differentiation
is an epigenetic regulatory process. This hypothesis is
consistent with the presence of large CpG islands in the
HIF1A promoter region (Table 2). It also agrees with
the observed decrease in methylation at the HIF1A pro-
moters of differentiated mast cells at three and five
weeks of culture (Fig. 3), which paralleled a significant
increase in HIF1A expression. Interestingly, the CD34
promoter, which also contains CpG islands (Table 2),
simultaneously demonstrated increased methylation that
paralleled decreased CD34 expression. The opposing
methylation statuses of these two genes suggests that
they represent components of a complex epigenetic
mechanism, which mediates cell maturation by silencing
the genes involved in maintaining the phenotype of
hematopoietic stem cells and upregulating the genes
necessary for mature mast cell functions.
There is experimental evidence that HIF1A is essen-
tial for the cell cycle quiescence of hematopoietic and
other stem cells, possibly due to its role in Notch-
dependent signaling (Bar et al. 2010; Mukherjee et al.
2011; Takubo et al. 2010). This implies that the amount
of HIF-1α mRNA in hematopoietic stem cells is distinct
from mature hematopoietic cells and is tightly regulated,
at least in part, by methylation of the HIF1A promoter region.
The change in the level of HIF1A promoter methylation upon
mast cell differentiation, resulting in increased levels of HIF-
1α mRNA, might be important for the regulation of multiple
HIF1A regulated genes that are necessary to maintain a mature
mast cell phenotype. This hypothesis is consistent with the
previously reported observations that the HIF1A product,
HIF-1α, plays a role in LPS-mediated TNF release in human
mast cells (Sumbayev et al. 2012) and our observations that
genes important for mast cell function, such as Kit and IL1A,
contain promoter HRE motifs (Table 3) and are influenced by
changes in oxygen concentrations (Table 4).
Previously reported epigenetic regulation of HIF1A ex-
pression has involved the methylation of DNA in the region
overlapping the HIF1A proximal promoter (Koslowski et al.
2010; Walczak-Drzewiecka et al. 2010). Considering the
sequence of the upstream region that showed decreased
methylation levels, one possible mechanism for the
upregulation of HIF1A is the demethylation of cytosines
that neighbor the HRE binding sites. These cytosines have
previously been shown to regulate the accessibility of the
Fig. 4 The methylation status of the human HIF1A and CD34 pro-
moters in differentiating human mast cells. Aliquots containing equal
numbers of CD133+ cells purified from the PBMC of two to four
anonymous blood donors were pooled and lysed for the extraction of
genomic DNA (CD133+). The remaining CD133+ cells were seeded
into separate flasks and cultured under mast cell differentiating condi-
tions. After 3 and 5 weeks of culture, aliquots containing equal num-
bers of cells originating from two to four blood donors were pooled
and lysed for the extraction of genomic DNA. The DNAwas analyzed
by a methylated CpG island recovery assay followed by real-time PCR
to determine the number of recovered HIF1A (a) promoter and CD34
(b) promoter sequences. The data represent the mean±SEM of three
DNA pools representing a total of eight donors
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HRE binding motif, which has been shown to positively
autoregulate HIF1A expression in colon cancer cells exposed
to hypoxia (Koslowski et al. 2010). However, the observed
increase in HIF1A expression in differentiating human mast
cells occurred under high concentrations of oxygen, and the
same HRE motif was also reported to mediate negative regu-
lation of HIF1A in other cell types (Xu et al. 2012).
Furthermore, there are other binding motifs at close proximity
Table 3 HIF1α binding motifs identified in the promoters of genes relevant for mast cell function. −2000/+100 sequences were scanned for
Putative HIF1α binding sites for each gene. Locations of putative binding sites are relative to the ATG initiation codon
Class Gene symbol Number of HRE Matrix similarity Sequence Strand
Preformed mediators CMA1 1 0.894 −124gaagaaaaCGTGaccat−108 (+)
CPA3 2 0.974 −1763catggaCGTGttttt−1749 (+)
0.698 −603ttcacCACGttggccag−587 (−)
CTSG 0
TPSAB1 3 0.973 −776gggtctcaCGTGttggccag−760 (+)
0.946 −731cccaccccCGTGgattc−715 (+)
0.976 −368cgggggcaCGTGttaca−352 (+)
TPSB2 2 0.946 −732gccaccccCGTGgattc−716 (+)
0.976 −368gggggCGTGttaca−716 (+)






IL1A 1 0.931 −786gtagcCACGTagccacg−770 (−)
IL1B 1 0.948 −857tcttctaaCGTGggaaa−841 (+)
IL4 0




IL13 2 0.975 −1998cggCAAGTgcgcgc−1985 (−)
0.945 −809gccagacaCGTGcacac−793 (+)
IL16 1 0.973 −1725gagCACGTagaccc−1712 (−)
IL18 1 0.892 −1600gggcaaCGTGgtgaa−1586 (+)
TGFB1 2 0.989 −1855gccccaCGTGgcggc−1841 (+)
0.871 −1645ctccaACGTcaccac−1631 (+)
TNF 1 0.975 +19atccgggaCGTGgagct+35 (+)
Chemokines CCL2 0
CCL3 1 0.955 +65ctgcatCACGtgagtct+81 (+)
CCL5 1 0.973 −41agacagcaCGTGgacct−25 (+)
Growth CSF2 1 0.986 −1141tgggcaCGTGtgggc−1127 (+)
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to the HREmotif, including SP1, that are necessary forHIF1A
promoter activity (Iyer et al. 1998; Minet et al. 1999).
In summary, we present evidence that during in vitro mast
cell differentiation, HIF1A expression is upregulated by an
epigenetic mechanism involving DNAmethylation. This sug-
gests that the baseline expression of HIF1A is epigenetically
regulated in a cell type- and differentiation stage-specific
fashion. Such precise regulation of HIF1A expression may
be important for the cellular response to varying oxygen
availability in particular organs and tissues.
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